Evaluation of adherence to national guideline for clinical follow up of hiv infected children using the proxy hematological, biochemical and anthropometric indicators of care

Ethiopian Medical Journal

Volumn 49, Issue 3, 2011, Pages 199-209

  Berhan, Yifru ^a  

^a HAWASSA UNIVERSITY   (Ethiopia)

Author keywords

ART; Haemoglobin; HIV infected children; Liver transaminase; Weight

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ANEMIA; ANTHROPOMETRY; ARTICLE; BLOOD; BODY HEIGHT; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; DRUG EFFECT; ETHIOPIA; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIVER; MALE; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; RETROSPECTIVE STUDY; STANDARD; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA; ANTHROPOMETRY; ANTI-HIV AGENTS; ASPARTATE AMINOTRANSFERASES; BODY HEIGHT; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LIVER; MALE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053631758     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS epidemic. www.unaids.org
2. Anniek De Baets, Marc Bulterys, Elaine Abrams, Chipepo Kankassa, Isidore Pazvakavambwa. Care and treatment of HIV-infected children in Africa: Issues and challenges at the district hospital level. Pediatr Infect Dis J. 2007; 26(2): 163-73.
3. Peter L Havens, Diana M Gibb. Increasing antiretroviral drug access for children with HIV infection. Pediatrics. 2007; 119(4): 838-45.
4. U D Feucht, M Kinzer, M Kruger. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children. J Trop Pediatr. 2007; 53(6):398-402.
5. World Health Organization and UNICEF. A clinical rqanual on Management of HIV infection & antiretroviral therapy in infants & children. 2006. http://www.searo.wlio.int/linkFiles/AIDSManagementofHIVinfection.pdf.
6. Federal HIV/AIDS Prevention and Control Office (HAPCO). Guidelines for Paediatric HIV/AIDS Care and treatment in Ethiopia. July 2008.
7. John G Bartlett, Martin S Hirsch, Barbara H McGovern. Patient monitoring during HIV antiretroviral therapy. UpToDate version 17.1: January 2009.
8. Buford Nichols, William J Klish, Kathleen J Motil, Alison J Hopin. Treatment of severe malnutrition in developing countries. UpToDate version 17.1: January 2009.
9. Newell ML, Borja MC, Peckham C. European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003; 111(1): 52-60.
10. World Health Organization. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers; 2001.
11. UNAIDS. Report on the Global AIDS Epidemic; 2006.
12. Bain BJ. Pathogenesis and pathophysiology of anaemia in HIV-infection. Curr Opin Hematol 1999; 6: 89-93.
13. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency vireus-1 on hematopoiesis. Blood. 1998; 91: 1479-5.
14. Heath KV; Hogg RS; Chan KJ; Harris M; Montessori V; O'Shaughnessy MV; Montanera JS. Lipodystrophyassociated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database. AIDS. 2001; 15(2):231-9. (Pubitemid 32142299)
15. Mallon PW; Miller J; Cooper DA; Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS. 2003; 17(7): 971-9. (Pubitemid 36549708)
16. Becker S. Liver toxicity in epidemiological cohorts. Clin Infect Dis 2004; 38: S49-55. (Pubitemid 38328165)
17. WHO. Iron Deficiency Anaemia. Assessment, Prevention, and Control: A guide for program managers, Geneva, World Health Organization Press, 2001; 40.
18. National Center for Chronic Disease Prevention and Health Promotion (CDC), United States, 2000. WAVw.cdc.gov/growthcharts.
19. Marisa Zanchetta, Alesssia Anselmi, Daniela Vendrame, and etal. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antivir Ther. 2008; 13(1): 47-55.
20. Avy Violari, Mark F Cotton, Diana M Gibb, and etal. Early Antiretroviral Therapy and Mortality among HIVinfected Infants. N Engl J Med. 2008; 359 (21): 2233-44.
21. Tim Niehues and Hermione Lyall. Antiretroviral Therapy in Children. In: Hoffmann-Rockstroh-Kamps. HIV Medicine. Flying Publisher. 2006; 375-9.
22. Christian Hoffmann, Fiona Mulcahy. Overview of antiretroviral agents. In: Hoffmann-Rockstroh-Kamps. HIV Medicine. Flying Publisher. 2006; 94-103.
23. Macroft A, Kirk O, Barton SE, Dietrich M, Proenca R, Colebunders R, etal. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from accross Europe. EuroSIDA Study Group. AIDS 1999; 13: 943-50. (Pubitemid 29240189)
24. Moore RD, Keruly JC, Chaison RE. Anaemia and survival in HIV infection. J Acqui Immune Defic Syndr Hum Retrovirol. 1998; 19:301-8.
25. UNAIDS. 2006 Report on the Global AIDS Epidemic: 2006.
26. Job C.J. Calis, Michael BV Hensbroek, Rob J.de Haan, Peter Moons, Bernard J Brabin & Imelda Bates. HIVassociated anemia in children: a systematic review from a global perspective. AIDS 2008; 22: 1099-112.
27. Diane G, James N, Carl L, Mary-ann D, Lesley W, Patti A and et al. Low Rates of Hepatotoxicity in HIVinfected Children on Anti-retroviral Therapy with and Without Isoniazid Prophylaxis. J Trop Pediatr 2009; 56 (3): 159-65.
28. Ana Cecilia M.G, Raquel Lorenzetti, Gun Bergsten M, Andre Moreno M, Aparacidia Dalbo C.T, Marcos Tadeu N.d. S, Mario Marluce d. S. V. Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy. Sao Paulo Med J. 2007; 125 (4) doi:1590/sl516. http//www.scielo.br/scieIo.php
29. Becker S. Liver toxicity in epidemiological cohorts. Clin Infect Dis. 2004; 38: s49-55. (Pubitemid 38328165)
30. Bjornsson E, Olsson R. Suspected drug-induced liver fatalities reported to WHO data base. Dig Liver Dis 2006; 38: 33-8. (Pubitemid 44356129)
31. Nunez M, Lana R, Mendoza JL, Martin-Carbonero L, Soriano V. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 27(5): 426-31. (Pubitemid 32801070)
32. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA. 2000; 283(1): 74-80. (Pubitemid 30038386)
33. Nunez M, Lana R, Mendoza JL, Martin-Carbonero L, Soriano V. Risk factors severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2001; 27(5): 426-31. (Pubitemid 32801070)
34. Nunez M, Soriano V. Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management. Drug Saf. 2005; 28(1): 53-66.